Medium materiality6/10
Halozyme price target raised to $95 from $75 at Wells Fargo
Why it may matterVerify against the original reporting
bearish
Public signal · 1-minute delayed
Signal brief
Source-backed market context you can read and share without an account.
AI summary
What happened, with direct paths to the underlying reporting
Wells Fargo raises Halozyme target to $95; Current price $103.12; Price change since signal -4.33.
- Wells Fargo raises Halozyme target to $95; Price $103.12.
Key facts
- 01
Target: $95
- 02
Posted price: $103.12
- 03
Analyst firm: Wells Fargo
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.